KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.9000
+0.0013 (0.14%)
Aug 19, 2026, 4:00 PM EDT - Market closed
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $16.73 million as of August 19, 2026. Its market cap has decreased by -72.21% in one year.
Market Cap
16.73M
Enterprise Value
7.97M
1-Year Change
-72.21%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $16.73M, a decrease of -96.11%. That is a compound annual growth rate of -30.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 16.70M | 263.04% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pluri | 18.99M |
| Tvardi Therapeutics | 17.64M |
| Citius Pharmaceuticals | 17.50M |
| NewcelX | 17.50M |
| Tempest Therapeutics | 17.10M |
| Lipocine | 16.90M |
| Pasithea Therapeutics | 16.37M |
| Vyome Holdings | 16.28M |